nanodiscs is accomplished by its addition to the initial lipid and MSP mixture. Microscale thermophoresis (MST) is a recently developed technology that studies interactions based on the differential movement of biomolecules and their complexes in a microscopic temperature gradient. MST is highly sensitive, since it depends on changes in the size, charge and hydration shell of molecules. It measures interactions in free solution (no coupling required) and needs only very low sample volumes. It thus provides advantages over existing techniques like fluorescence correlation spectroscopy (FCS), isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR). The use of nanodiscs in MST-based interaction studies of membrane proteins with ligands, or of lipid membranes with soluble peptides is very appealing. We thus explored this approach experimentally. Potential pitfalls of the method (aggregation of nanodiscs, undesired interactions with the capillary walls, etc.) were addressed and ways to overcome such difficulties are presented. Finally, MST was successfully applied for the measurement of binding affinities between various membrane proteins and their ligands.
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2863-Pos Board B18
Design and Testing of High-Affinity Mutants of Interferon Gamma Receptor 1 Pavel Mikulecky, Jiri Cerny, Lada Biedermannova, Peter Sebo, Bohdan Schneider. Institute of Biotechnology AS CR, v.v.i., Prague 4, Czech Republic. Specific protein-protein interactions control many crucial processes of the living cell. We aim at elucidating specificity of the interactions at the model system of interferon gamma (IFNg) and its cellular receptor 1 (IFNgRec1), the system important in innate immunity. To modulate (increase as well as decrease) specificity of the interaction we searched for mutations of the receptor molecule that was subjected to in silico mutations using the crystallographically determined structures of IFNg/IFNgRec1 complex. Amino acid substitutions were modeled by empirical force field implemented in the web-based software FoldX. About twenty computer-selected candidate mutants of IFNgRec1 were successfully expressed in Escherichia coli, purified to homogeneity and their affinities to IFNg were determined by surface plasmon resonance (SPR). The SPR measurements showed that affinity of most receptor variants designed for affinity increase had their affinity virtually unchanged, a few had affinity slightly lower but a few bound with affinity significantly higher. Simple and computationally cheap method was therefore able to predict increase of affinity. The receptor variants with increased affinity may be used for diagnostic purposes. Acknowledgements. Support from grant P305/10/2184 from the Czech Science Foundation is greatly acknowledged. All authors are supported by the institutional grant AV0Z50520701. 
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þ antiporter belonging to the CLC family, which includes both Cl À channels and Cl À /H þ antiporters. Small organic molecules have been useful tools for studying ion channels and many commercial drugs target specific ion channel proteins. Some blockers have been found to inhibit the plasma membrane localized CLC channels ClC-0, ClC-1 and ClC-Ka. However, high-affinity ligands for most CLCs are missing. Here, we tested the benzofuran derivative RT-93 1,2 on ClC-5 and ClC-4. Interestingly RT-93 inhibits ClC-5 (EC50~200 mM), but has only a small effect on the highly homologous antiporter ClC-4. Towards our goal to identify the binding site of RT-93 on ClC-5, we constructed 12 chimeras between ClC-4 and ClC-5. Guided by the crystal structure of a bacterial CLC protein and using the alignment between ClC-4 and ClC-5, we identified the sequence stretches with the main differences between these two proteins and substituted in ClC-5 the portions with the corresponding sequence of ClC-4. We expect to remove the RT-93 sensitivity at least in one of these. So far we tested 8 chimeras, none of which, however, showed a significant difference in comparison with ClC-5. If none of the chimeras eliminates the binding site we will proceed with constructing larger chimeras. Discovering the binding site of this blocker might help in creating a more efficient ligand that, apart from being a useful biophysical tool, may provide a way to modulate protein function in vivo. 2865-Pos Board B20 Cloning, Expression, and Purification of a Centrin Biological Target: Krr1, KH Domain Aslin M. Rodriguez, Belinda Pastrana-Rios. University of Puerto Rico at Mayaguez, Mayaguez, Puerto Rico. The origin of many disease states has been linked to genetic mutations, defects in gene expression, nuclear excision repair and ribosome biogenesis. Centrin, a calcium binding protein, which has recently been found to regulate some of these processes along other target proteins within the nucleus. One target, Krr1, contains a K homology (KH) domain; which has been identified as a nucleic acid recognition motif, required for proper processing of pre-rRNA, for synthesis of 18S rRNA, and for the assembly of the 40S subunit. Our initial findings have identified a putative centrin binding site located within the KH domain of Krr1 using bioinformatics tools. In this study, the KH domain (192 bp) was amplified by PCR and then ligated to the expression vector pET100. Colony PCR was performed to identify the E. coli colonies that have been transformed effectively with the desired recombinant. The Krr1 KH domain fragment was then overexpressed. An isolation and purification protocol has been designed which includes preparative centrifugation, cross flow and tangential flow filtration and two ion exchange chromatography. The evaluation of the purification of the KH domain fragment has been performed by SDS-PAGE and peptide samples have been sent for MS analysis and partial amino acid sequencing.
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Recognition of Mesothelin by the Therapeutic Antibody MORAB-009: Structural and Mechanistic Insights Wai Kwan Tang. National Institutes of Health, Bethesda, MD, USA. Mesothelin is a cell surface protein that is normally found in mesothelial cells lining the pleura, pericardium and peritoneum, but is aberrantly expressed at high level in a variety of cancers including mesothelioma, ovarian, pancreatic and lung cancers. Although the physiological function of mesothelin is unclear, studies have shown that it is capable of binding to the tumor antigen CA-125 (also known as MUC16), leading to cell adhesion and tumor metastasis. Since mesothelin is specifically expressed at a significantly higher level in malignant tumors, development of an antibody against mesothelin is therefore of major importance in the field of cancer therapy. MORAb-009 is a humanized monoclonal antibody against mesothelin currently under clinical trials. Animal experiments have shown that application of MORAb-009 in combination with chemotherapy leads to a marked reduction in tumor growth of mesothelinexpressing tumors. We show here that MORAb-009 recognizes a non-linear epitope that is contained in the first 64-residue fragment of the mesothelin. We further demonstrate that the recognition is sensitive to the loss of a disulfide bond linking residues Cys7 and Cys31. The crystal structure of the complex between the mesothelin N-terminal fragment and Fab of MORAb-009 at 2.6 Å resolution reveals an epitope encompassing multiple secondary structural elements of the mesothelin, The mesothelin fragment has a compact, right-handed superhelix structure consisting of five short helices and connecting loops. A residue essential for complex formation has been identified as Phe22, which projects its side chain into a hydrophobic niche formed on the antibody's recognition surface upon antigen-antibody contact. The overlapping binding footprints of both the monoclonal antibody and the cancer antigen CA125 explains the therapeutic effect and provides a basis for further antibody improvement. [(2-pyrimidinylthio) acetyl]benzenesulfonamides were designed and synthesized. their binding affinities as inhibitors of several recombinant human carbonic anhydrase (CA) isozymes were determined by isothermal titration calorimetry and thermal shift assay yielding intrinsic Gibbs free energies, enthalpies, entropies, and heat capacities of binding. A group of compounds containing a chlorine atom in the benzenesulfonamide ring were found to exhibit higher selectivity but lower binding affinity toward tested CAs. The crystal structures of selected compounds in complex with several CAs were determined and the docking studies were performed to compare the binding 558a Wednesday, February 6, 2013 
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